Dear all:
The Global Drug Facility has published new EoIs for anti-TB medicines
evaluation (medicines not Prequalified by WHO PQP nor approved by a
stringent regulatory authority).
The combined EoI (GDF and Global Fund) for first line anti-TB medicines
evaluation and the second EoI for second and third line anti-TB medicines
evaluation have been posted in GDF website at
http://www.stoptb.org/gdf/drugsupply/procurement_notice.asp.
Could you please assist us on disseminating this information as widely as
possible among your colleagues and partners in the regions and countries?
I am also pleased to announce that the GDF Quality Assurance Policy and
Procedures 2010 is now posted at
http://www.stoptb.org/gdf/drugsupply/quality_sourcing_process.asp
Thanks a lot and kind regards,
Paloma
Paloma Marroquín Lerga
Technical Officer / Pharm., MPH
The Global Drug Facility
Stop TB Partnership Secretariat
World Health Organization
20, Avenue Appia, CH-1211 Geneva 27
Direct telephone: +41 22 791 2612;
Fax: +41 22 791 4886
Email: lergap@who.int
http://www.stoptb.org/gdf/